meditating on the next stock to buy.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
who is the packer of the coffee line ?,...what is the delay on corporate update?,...why so many shares at .0001 ?,...is ceo diluting?
if its a major bottler how high does anyone know this pps will go?
ID Global Corporation Announces New Advisory
Board Member and Strategic Partner
Chicago, Illinois--(September 18, 2014) – ID Global Corp. (OTC: IDGC) is pleased to announce
the addition of a new Advisory Board member, William Tynan. Mr. Tynan has over 25 years of
financial experience, analytic and accounting, in various sectors including: Logistics and
Transportation, Oil and Gas and commercial real estate development. His career began at Price
Waterhouse Coopers auditing public and private companies including Fortune 500 companies,
start-up’s and IPO’s and is now working as a strategic business consultant.
Sebastien DuFort, president and CEO stated "We are very excited to have Mr. Tynan as part of
our team. He brings a great deal of experience with him that will prove useful to our most recent
corporate direction. He will also serve as a key partner in expanding our resources related to
financing and help build additional revenue streams for IDGC.”
THERAPY CELLS, INC.
Notes to Condensed Financial Statements (continued)
(Unaudited)
NOTE 6– INTELLECTUAL PROPERTY RIGHTS
Therapy Cells Inc announced in 2013 that on12 February 2013, US patent 8,372,644 was awarded Dr P Casey, et al. The Assignee
under that patent number is Transplantation Ltd, a company registered in New Zealand. Transplantation Ltd has exclusively
invested in Therapy Cells Inc a licence for the use of the process for equine and human applications. Due to funding constraints
we have been unable to progress the approval process from the US Food and Drug Administration (FDA) for human applications.
Our funding activity has increased significantly over the last quarter and we are close to finalising a long-term funding
arrangemet that will allow us to fast-track the FDA process.
the month of September should be a tell tale sign of the one and first of products to be produced OR FINALIZED ON,...I think the last pr stated one of the products would be ready for distribution,...hope there are no more delays,...gl to IDGC and CEO and SHAREHOLDERS.
WOW,...look at all that money setting on the bid wanting in at .0004,....if they would slap the ask we would be at .008 by now,...if the shorts would slap the ask this will move up.
its not dumping,...its buys being filled on the bid,...learn how to trade.
INSIDE RUMOR,...GOOD NEWS IS COMING WITH ALL DEALS FINALIZED,...HOW I KNOW I KNOW,...IDGC WILL SUCCEED.
all kidding aside,...if this ceo is smart and he can put this together this will make a lot of us here some big money if,...and I say if he can put this together,...I believe he will try his best but there are still no guarantees,...high risk equals high payoffs,...small risk equal small payoffs and no risk equal no payoffs,...gl.
I heard it cost over 2000 dollars to do a market press release,...looks like this is not gonna move unless pr comes out,...hopefully a good pr,...looks like no one is buying or selling,...anyone hear from ceo,...they now have a facebook page to contact them,...gl to all,...I will be here till the cows come home.
lol,...now that's funny.
soooooooo,...I guess idgc is trying to raise capitol in order to move forward,...my question is where are they gonna get it from besides dilution on a small scale according to ceo,...there seems to always be something holding a company back from moving forward,...does anyone know what is the next stage for this company besides what I have already commented on?,...I guess if outside financing was to happen this would be good but I do not see ceo mentioning this in pr.
website still looks like crapola,...no pr's to shareholders,...no updates,...no live broadcast,...no nothing,...still looks like a scam to me,...newbies beware,...james wright does not care about you.
buyers are setting on the bid,...sellers are setting on the ask,...more buyers then sellers.
whats the rumor with starbucks and idgc?,...I cant find much information on this,...anyone else know much?
did anyone know there is a DTC CHILL ON THIS STOCK?
newbi here,...I don't see anything stating a r/s in any pr's,...where is this coming from?,...cause am thinking about adding here.
this stock will go no where but down even farther unless ceo starts caring about this company,...he has done nothing but delay, delay, and more delays,...no pr's,...website layout looks goofy,...nothing to show for our investment,...ceo has made it plain he does not have respect for shareholders and could careless what anyone thinks,...r/s at this time could be a reality if this dips to the .0003's,...this was a good concept but the wrong people are in charge,...ceo does not care about YOU!,...red flags where all over this way before chris left and new ceo has done even worse,...gl.
I followed you.
newbi here,...whats with all the negativity here?,...anyone have hope this might go up from here?
for what its worth,...heads up,...a friend of mine e-mailed ceo yesterday morning and received a response four minutes later stating more news to come soon,..ceo stated a lot of stuff going on for the company and many updates to report on,...ceo stated very excited with loi's but cannot comment until concrete deals are done,...also other companies involved with idgc but cannot name at this time until deals are done,...next pr should be soon,...gl.
that's not what we are here for,...we are here for what might happen if ceo can tie up all the lose ends,...every penny stock is a miss and hit,...you never know which one will make it,...but this company has a good concept in place and we have been informed to what he is doing from pr's,...another pr will be here soon on his progress,...you will know if its worth staying around or not,...so am hanging in there till I see different,...gl.
there website looks really bad,...not professional at all,...ceo has no respect for shareholders,...I think he is doing a really bad job,...this stock is done unless ceo starts pr back up and communicate like one should do.
fact,...ceo has a deal with corr brands,...fact ceo has posted everything he is doing,...final stage of first product coming soon,...next product rolling out right after,...fact,...PepsiCo has done work for corr brands,...hemp drink is gonna be a winner,...cant wait to buy some of that drink,...I bet it taste good.,...when it all comes together its going to be a great company.
slap those 9's you greedy bums,...lol.
nice read,...time to buy more,...thanks.
lol,...you will never get it.
lol,...you will be waiting for ever then,...idgc.
lol,...its no worse then what YOU are trying to do now by shorting this stock for your own gain,...you are trying to drive the pps down so you can buy and then sell at two ticks up,...who is worse you or him,...lol.
lol,...then sell and move on.
lol,...when the bashers are out its a good sign to hold,...they want yours shares as cheap as they can get,....buy and hold,...it will pop on the next news out.
"GREAT NEWS COMING" BUY,BUY,BUY.,...IDGC.
just my opinion,...if the co. is trying to raise funds for fda approval of 2 million dollars target range but have come short would it be logical for them to get with a company that has money?,... so they can finish up on the trials for humans,...seems like there might be a little greed going on since the company tcel holds a patent on one of the most highly phenomenal stem cell research in history,...and has already proven results on horse tendons,...if they would share some money and the patent with others I think they would get what they need to finish this project,...jmo.
6) Describe the Issuer’s Business, Products and Services
Describe the issuer’s business so a potential investor can clearly understand the company. In answering this item, please
include the following:
A. a description of the issuer’s business operations;
The Company’s business operations consist of doing business in the cell repair and cell replacement for Equine stock
at present, but we are pursuing FDA approval for existing and modified products to be used for the repair of the
Human Body. Its products have been successfully utilised for the repair of horses tendons and have the added bonus
of being patented in the name of the Company. In October 2013 we had to cease trialing the process due to lack of
available and sustainable funds. The new initiative to generate investment into the company will allow us to
recommence these trials and move towards selling the product on the open market. As a result, the Company is still in
development and approval stage.
In February 2014 we appointed an IR company who are looking to raise the estimated $2million required to obtain
FDA approval of the patented process to make the product available to our targeted markets. This process has
continued and has found some succes following the release into the market of converted stocks although we are still
short of our targetted investment level which would allow trials to recommence.
Beneficial Shareholders. Provide a list of the name, address and shareholdings or the percentage of shares
owned by all persons beneficially owning more than ten percent (10%) of any class of the issuer’s equity
securities. If any of the beneficial shareholders are corporate shareholders, provide the name and address of the
person(s) owning or controlling such corporate shareholders and the resident agents of the corporate
shareholders.
Redwood Management of 16850 Collins Ave. Ste 112-341, Sunny Isles, Florida 33160. Controlling members of
Redwood Managemet are Gary Rogers and John Denobile of the same address. Redwood Management controls
42,658,230 Common Stock = 27.8%
No other individual controls more than 10% of the Company's equity
3) Security Information
Trading Symbol: TCEL
Exact title and class of securities outstanding: Common shares and Preferred shares
CUSIP: 88337C102
Par or Stated Value: Common shares par is $0.0001 and Preferred shares par is $0.0001
Total shares authorized: Common shares 500,000,000; Preferred shares 100,000,000 as of:
03/31/2014
Total shares outstanding: Common shares 153,205,589; Preferred shares 2,803,757 as of:
03/31/2014
Transfer Agent
Name: Action Stock Transfer Corp
Address 1: 7069 S. Highland Dr, Ste 300
Address 2: Salt Lake City
Address 3: Utah 84121
Phone: 801-274-1088
Is the Transfer Agent registered under the Exchange Act?* Yes: No:
*To be included in the OTC Pink Current Information tier, the transfer agent must be registered under the Exchange Act.
Interim Report to 31 March 2014
Information contained in a Financial Report is considered current until the due date for the subsequent Financial Report.
To remain in the OTC Pink Current Information tier, a company must post its Annual Report within 90 days from its fiscal
year-end date and Quarterly Reports within 45 days of its fiscal quarter-end date.
6) Describe the Issuer’s Business, Products and Services
Describe the issuer’s business so a potential investor can clearly understand the company. In answering this item, please
include the following:
A. a description of the issuer’s business operations;
The Company’s business operations consist of doing business in the cell repair and cell replacement for Equine stock
at present, but we are pursuing FDA approval for existing and modified products to be used for the repair of the
Human Body. Its products have been successfully utilised for the repair of horses tendons and have the added bonus
of being patented in the name of the Company. In October 2013 we had to cease trialing the process due to lack of
available and sustainable funds. The new initiative to generate investment into the company will allow us to
recommence these trials and move towards selling the product on the open market. As a result, the Company is still in
development and approval stage.
In February 2014 we appointed an IR company who are looking to raise the estimated $2million required to obtain
FDA approval of the patented process to make the product available to our targeted markets. This process has
continued and has found some succes following the release into the market of converted stocks although we are still
short of our targetted investment level which would allow trials to recommence.
yes,...if all the bid sitters would hit the ask like me this will be moving back up again and they would make more money then bid sitting,...jmo.